4//SEC Filing
Naftzger J. Christopher 4
Accession 0001447028-23-000066
CIK 0001447028other
Filed
Jul 11, 8:00 PM ET
Accepted
Jul 12, 4:12 PM ET
Size
6.0 KB
Accession
0001447028-23-000066
Insider Transaction Report
Form 4
Naftzger J. Christopher
General Counsel and CCO
Transactions
- Award
Stock Option (Right to Buy)
2023-07-10+500,000→ 500,000 totalExercise: $2.26Exp: 2033-07-10→ Common Shares (500,000 underlying)
Footnotes (2)
- [F1]Reflects the closing price of the Issuer's common shares on the Nasdaq Stock Market on July 10, 2023, the date of the grant.
- [F2]This option shall vest over a four-year period, with 25% of the shares subject to the option vesting on the first anniversary of the grant date and the remaining 75% of the shares subject to the option vesting over the subsequent three-year period in substantially equal monthly installments at a rate of 1/48th of the total shares subject to the option each month, subject to the Reporting Person's continuous service as of each vesting date.
Documents
Issuer
Arbutus Biopharma Corp
CIK 0001447028
Entity typeother
Related Parties
1- filerCIK 0001496194
Filing Metadata
- Form type
- 4
- Filed
- Jul 11, 8:00 PM ET
- Accepted
- Jul 12, 4:12 PM ET
- Size
- 6.0 KB